GP17

1 paper2 findings

Humans1

Effects

1

GDF-15

downin humans1OR 0.709

1 study

GP17 decreases GDF-15 (OR 0.709, 95% CI 0.504–0.995).
“GP17 (OR = 0.709, 95%CI = 0.504-0.995) with growth/differentiation factor 15 (GDF15)”
HumansForward Mendelian randomization
Bidirectional Two-Sample Mendelian Randomization Study of Immunoglobulin G N-Glycosylation and Senescence-Associated Secretory Phenotype
International journal of molecular sciences7 Jun 2024

Associations

1

RAGE

upin humans1OR 1.125

1 study

RAGE is associated with GP17 (OR 1.125, 95% CI 1.003–1.261).
“genetic liability to RAGE was associated with increased levels of GP17 (OR = 1.125, 95% CI = 1.003-1.261)”
HumansGenetic liability to RAGE in reverse Mendelian randomization
Bidirectional Two-Sample Mendelian Randomization Study of Immunoglobulin G N-Glycosylation and Senescence-Associated Secretory Phenotype
International journal of molecular sciences7 Jun 2024

Latest

International Journal of Molecular Sciences27 Jun

Bidirectional Two-Sample Mendelian Randomization Study of Immunoglobulin G N-Glycosylation and Senescence-Associated Secretory Phenotype

Mendelian randomisation in peopleSenescence-associated secretory phenotype (SASP)